{
    "clinical_study": {
        "@rank": "11607", 
        "arm_group": [
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 1 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 2 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 3", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 3 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 4", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 4 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 5", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 5 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "OnabotulinumtoxinA Dose 6", 
                "arm_group_type": "Experimental", 
                "description": "OnabotulinumtoxinA Dose 6 injected into specified muscle per protocol on Day 1."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo (normal saline) injected into specified muscle per protocol on Day 1."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a safety and efficacy study of BOTOX\u00ae (onabotulinumtoxinA) for the treatment of\n      premature ejaculation in male patients."
        }, 
        "brief_title": "A Safety and Efficacy Study of BOTOX\u00ae in Premature Ejaculation", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Premature Ejaculation", 
        "condition_browse": {
            "mesh_term": "Sexual Dysfunctions, Psychological"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of premature ejaculation\n\n          -  Stable monogamous sexual relationship with female partner for at least 6 months, and\n             intends to continue with the same partner for the duration of the study\n\n          -  Patient has ability to follow study instructions and complete study assessment tools\n\n        Exclusion Criteria:\n\n          -  Premature ejaculation caused by medical or surgical issues, or is related to stress\n             or other issues (eg, relationship problems)\n\n          -  Pain with ejaculation\n\n          -  Planned use of topical penile treatments (eg, anesthetics, herbal treatments) or\n             penile injections during the study\n\n          -  Prior genital, prostatic or lower urinary tract surgery (other than vasectomy or\n             circumcision)\n\n          -  Previous or current usage of botulinum toxin therapy of any serotype for any\n             urological condition\n\n          -  Use of botulinum toxin therapy of any serotype for any nonurological condition (eg,\n             cosmetic, chronic migraine) during the 12 weeks prior to screening, or planned usage\n             during the study\n\n          -  Diagnosis of Myasthenia gravis, Eaton\u2010Lambert Syndrome, Amyotrophic Lateral Sclerosis"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917006", 
            "org_study_id": "191622-133", 
            "secondary_id": "2013-001650-94"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "OnabotulinumtoxinA Dose 1", 
                    "OnabotulinumtoxinA Dose 2", 
                    "OnabotulinumtoxinA Dose 3", 
                    "OnabotulinumtoxinA Dose 4", 
                    "OnabotulinumtoxinA Dose 5", 
                    "OnabotulinumtoxinA Dose 6"
                ], 
                "description": "OnabotulinumtoxinA injected into specified muscle per protocol on Day 1.", 
                "intervention_name": "OnabotulinumtoxinA", 
                "intervention_type": "Drug", 
                "other_name": [
                    "BOTOX\u00ae", 
                    "Botulinum Toxin Type A"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo (normal saline) injected into specified muscle per protocol on Day 1.", 
                "intervention_name": "Normal Saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 17, 2014", 
        "link": [
            {
                "description": "Study Website", 
                "url": "http://www.PEproblems.com"
            }, 
            {
                "description": "More Information", 
                "url": "http://www.allerganclinicaltrials.com"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlebury", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "7", 
        "overall_contact": {
            "email": "clinicaltrials@allergan.com", 
            "last_name": "Allergan Inc."
        }, 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline in Geometric Mean Intravaginal Ejaculatory Latency Time (IELT)", 
            "safety_issue": "No", 
            "time_frame": "Baseline, Week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917006"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline in Average IELT", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 2, 4, 6, 8, 10, and 12"
            }, 
            {
                "measure": "Change from Baseline in Geometric Mean IELT", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 2, 4, 6, 8, and 10"
            }
        ], 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}